Discontinuation report CARBOCAINE 2% WITH NEO-COBEFRIN
Report ID | 204402 |
Drug Identification Number | 02474182 |
Brand name | CARBOCAINE 2% WITH NEO-COBEFRIN |
Common or Proper name | CORBADRINE & MEPIVACAINE HCl solution |
Company Name | NOVOCOL PHARMACEUTICAL OF CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CORBADRINE MEPIVACAINE HYDROCHLORIDE |
Strength(s) | 0.05MG 20MG |
Dosage form(s) | SOLUTION |
Route of administration | BLOCK/INFILTRATION BLOCK/INFILTRATION |
Packaging size | Box of 50 Cartridges of 1.8 mL each |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for discontinuation | Raw material availability |
Anticipated discontinuation date | |
Actual discontinuation date | 2023-03-20 |
Remaining supply date | 2023-08-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 25 WOLSELEY COURT CAMBRIDGE, ONTARIO CANADA N1R 6X3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2023-09-15 | French | Compare |
v1 | 2023-09-15 | English | Compare |
Showing 1 to 2 of 2